DFPH — Stock Film
STOCK FILMSCENE 1/10DFPH · $2.01
Stock Expert AI presents
DFPH
DFP Healthcare Acquisitions Cor
~3 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
DFP Healthcare Acquisitions Cor. A quick introduction.

On the stock market since 2025, it operates in the everyday-essentials business. Now — the numbers.

on the stock market since 2025
$436.4M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $1.4.

The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.

WHERE DOES THE MONEY COME FROM?
50%Health Care, Patient Service
Health Care, Patient Service 50%Fee for Service 32%Capitated Revenue 17%Clinical Research Trials and Other Revenue 1%
50% of all revenue comes from a single line: Health Care, Patient Service.

The biggest line carries real weight, but it doesn’t decide everything on its own.

In the vault right now:
$0
DEBT: $135K
At this pace, that money lasts about 2.9 years.

Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
The stock has lost its spark0/10
Costs eat into the margin4/10
WORTH WATCHING

Cost Efficiency: As sales grow, profit fails to keep the same pace.

THE FIVE-YEAR JOURNEY
Bumpy, but the direction is up.

The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.

1
THE BRIGHT SIDE · 1/2
The product is selling

Sales run at $1.2M a year. A small number, but proof the product has real buyers.

2
THE BRIGHT SIDE · 2/2
Strong cash, light debt

There is $1.3M in the vault; even if every debt were paid off, $1.2M would remain.

1
THE RISKS · 1/2
Small sales, big loss

A loss of $454K against $1.2M in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/2
A wildly swinging price

This stock swings about 3 times as much as the market average. Big rallies — and big drops — can both happen fast.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, DFPH sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: DFPH is a high-risk stock — not yet profitable, and its future rides on its product catching on.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film